LT3000466T - Retinochorioidinių sutrikimų slopiklis - Google Patents

Retinochorioidinių sutrikimų slopiklis

Info

Publication number
LT3000466T
LT3000466T LTEP14800477.3T LT14800477T LT3000466T LT 3000466 T LT3000466 T LT 3000466T LT 14800477 T LT14800477 T LT 14800477T LT 3000466 T LT3000466 T LT 3000466T
Authority
LT
Lithuania
Prior art keywords
inhibitor
retinochoroidal disorders
retinochoroidal
disorders
Prior art date
Application number
LTEP14800477.3T
Other languages
English (en)
Inventor
Kazuhiro Kimura
Original Assignee
Yamaguchi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamaguchi University filed Critical Yamaguchi University
Publication of LT3000466T publication Critical patent/LT3000466T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J9/00Feeding-bottles in general
    • A61J9/08Protective covers for bottles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LTEP14800477.3T 2013-05-22 2014-05-21 Retinochorioidinių sutrikimų slopiklis LT3000466T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013107706 2013-05-22
PCT/JP2014/002667 WO2014188716A1 (ja) 2013-05-22 2014-05-21 網脈絡膜障害の抑制剤

Publications (1)

Publication Number Publication Date
LT3000466T true LT3000466T (lt) 2019-02-11

Family

ID=51933283

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14800477.3T LT3000466T (lt) 2013-05-22 2014-05-21 Retinochorioidinių sutrikimų slopiklis

Country Status (22)

Country Link
US (2) US10702502B2 (lt)
EP (2) EP3000466B1 (lt)
JP (2) JP6407145B2 (lt)
KR (1) KR102303316B1 (lt)
CN (1) CN105377258B (lt)
AU (1) AU2014269762B2 (lt)
BR (1) BR112015029114B1 (lt)
CA (1) CA2913005C (lt)
CY (1) CY1121036T1 (lt)
DK (1) DK3000466T3 (lt)
ES (1) ES2694831T3 (lt)
HK (1) HK1221909A1 (lt)
HR (1) HRP20181876T1 (lt)
LT (1) LT3000466T (lt)
MX (1) MX362239B (lt)
PL (1) PL3000466T3 (lt)
PT (1) PT3000466T (lt)
RS (1) RS58045B1 (lt)
RU (1) RU2672057C2 (lt)
SI (1) SI3000466T1 (lt)
WO (1) WO2014188716A1 (lt)
ZA (1) ZA201508940B (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3721880T3 (pl) 2010-09-01 2022-05-23 Thomas Jefferson University Kompozycja i sposób naprawy i regeneracji mięśni
KR102173932B1 (ko) 2012-11-08 2020-11-04 고쿠리츠다이가쿠호우진 야마구치 다이가쿠 각결막 장해의 치료제
RU2672057C2 (ru) * 2013-05-22 2018-11-09 Ямагути Юниверсити Ингибитор хориоретинальных нарушений
CA3025854A1 (en) 2016-06-08 2017-12-14 Clementia Pharmaceuticals Inc. Methods for treating heterotopic ossification
EA039050B1 (ru) * 2016-11-16 2021-11-26 Клементиа Фармасьютикалс Инк. Способы лечения множественного остеохондроматоза (мо)

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9307784A (pt) 1993-01-11 1995-11-14 Ligand Pharm Inc Compostos tendo seletivamente para receptores de retinóide X
US5824685A (en) * 1995-02-01 1998-10-20 The Johns Hopkins University School Of Medicine Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
US5624957A (en) 1995-06-06 1997-04-29 Bristol-Myers Squibb Company Rary-specific retinobenzoic acid derivatives
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US7514074B2 (en) 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6204288B1 (en) 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
US6313168B1 (en) 1999-12-15 2001-11-06 Allergan Sales, Inc. Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
US20030114482A1 (en) 1999-12-15 2003-06-19 Maurizio Pacifici Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
EP1265637A2 (en) 2000-03-14 2002-12-18 The University Of Western Ontario Compositions and methods for affecting osteogenesis
DK1324970T3 (da) 2000-10-02 2009-01-05 Hoffmann La Roche Retinoider til behandling af emfysem
CA2460693C (en) 2001-09-18 2010-12-07 F. Hoffmann-La Roche Ag Alkyl urea retinoid agonists i
ES2325063T3 (es) 2001-09-18 2009-08-25 F. Hoffmann-La Roche Ag Agonistas de retinoide ii de urea sustituida.
AUPR892501A0 (en) 2001-11-16 2001-12-13 Peter Maccallum Cancer Institute, The Method of enhancing self renewal of stem cells and uses thereof
US20050101581A1 (en) 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
JP2005206544A (ja) 2004-01-23 2005-08-04 Yasuyoshi Uchida 筋肉再生剤
AU2005240078A1 (en) 2004-04-30 2005-11-17 Allergan, Inc. Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
WO2006101972A2 (en) * 2005-03-17 2006-09-28 Elan Pharma International Limited Injectable compositions of nanoparticulate immunosuppressive compounds
US7345931B2 (en) 2005-08-01 2008-03-18 Infineon Technologies Ag Maintaining internal voltages of an integrated circuit in response to a clocked standby mode
CN101316584A (zh) 2005-09-27 2008-12-03 北海道公立大学法人札幌医科大学 用于预防及治疗由血管通透性亢进引起的眼病的医药
KR20070037188A (ko) 2005-09-30 2007-04-04 현대자동차주식회사 자동 변속기에서 유량 제어구조
BRPI0709886A2 (pt) * 2006-03-31 2011-07-26 Hoffmann La Roche processo para a preparaÇço de compostos retinàides
EP2026778B1 (en) 2006-05-16 2018-11-14 Io Therapeutics, LLC Rar antagonist or inverse agonist for use in the treatment of chemotherapy and/or radiation therapy side effects
AU2007313822A1 (en) 2006-10-27 2008-05-08 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
WO2008063842A2 (en) * 2006-11-02 2008-05-29 Aestus Therapeutics, Inc. Methods of treating neuropathic pain with agonists of ppar-gamma
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
JP2009235031A (ja) 2008-03-28 2009-10-15 Nano Egg:Kk 角膜組織の再生促進剤
US8969350B2 (en) 2008-12-18 2015-03-03 Astrazeneca Ab Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
WO2010088735A1 (en) 2009-02-05 2010-08-12 Regenertech Pty Ltd Method of producing progenitor cells from differentiated cells
PL3721880T3 (pl) 2010-09-01 2022-05-23 Thomas Jefferson University Kompozycja i sposób naprawy i regeneracji mięśni
US20120077786A1 (en) 2010-09-27 2012-03-29 Byron David A Methods and compositions for disease treatment using inhalation
CN103702967A (zh) 2011-03-14 2014-04-02 貝丝以色列女执事医疗中心 用于治疗增殖性病症的方法和组合物
WO2012129562A2 (en) 2011-03-24 2012-09-27 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
US8772273B2 (en) 2011-10-04 2014-07-08 Quretino Therapeutics, Inc. Formulations and uses of retinoic acid receptor selective agonists
KR102173932B1 (ko) 2012-11-08 2020-11-04 고쿠리츠다이가쿠호우진 야마구치 다이가쿠 각결막 장해의 치료제
RU2672057C2 (ru) * 2013-05-22 2018-11-09 Ямагути Юниверсити Ингибитор хориоретинальных нарушений

Also Published As

Publication number Publication date
EP3000466A4 (en) 2017-01-25
US20210121442A1 (en) 2021-04-29
CA2913005A1 (en) 2014-11-27
RU2672057C2 (ru) 2018-11-09
JP6407145B2 (ja) 2018-10-17
US20160120843A1 (en) 2016-05-05
HK1221909A1 (zh) 2017-06-16
BR112015029114B1 (pt) 2020-11-24
SI3000466T1 (sl) 2019-02-28
BR112015029114A8 (pt) 2020-03-17
DK3000466T3 (en) 2018-11-26
AU2014269762A1 (en) 2016-01-07
ES2694831T3 (es) 2018-12-27
AU2014269762B2 (en) 2019-09-12
RS58045B1 (sr) 2019-02-28
PT3000466T (pt) 2018-11-27
RU2015154741A (ru) 2017-06-28
JP2018115221A (ja) 2018-07-26
KR102303316B1 (ko) 2021-09-23
CN105377258B (zh) 2020-08-28
MX362239B (es) 2019-01-09
PL3000466T3 (pl) 2019-04-30
EP3000466A1 (en) 2016-03-30
EP3446690A1 (en) 2019-02-27
BR112015029114A2 (pt) 2017-07-25
ZA201508940B (en) 2017-11-29
WO2014188716A1 (ja) 2014-11-27
JP6749962B2 (ja) 2020-09-02
CY1121036T1 (el) 2019-12-11
MX2015016083A (es) 2016-03-21
CN105377258A (zh) 2016-03-02
NZ715245A (en) 2021-04-30
EP3000466B1 (en) 2018-08-15
US11730718B2 (en) 2023-08-22
HRP20181876T1 (hr) 2019-03-08
CA2913005C (en) 2021-08-10
JPWO2014188716A1 (ja) 2017-02-23
KR20160013075A (ko) 2016-02-03
US10702502B2 (en) 2020-07-07

Similar Documents

Publication Publication Date Title
GB201307577D0 (en) New compounds
AP2015008713A0 (en) Tetrahydropyrrolothiazine compounds
GB201302927D0 (en) Compounds
HK1211578A1 (en) Amidoimidazopyridazines as mknk-1 kinase inhibitors mknk-1
HK1216531A1 (zh) 新的抑制劑
GB201304526D0 (en) New compounds
GB201317609D0 (en) Inhibitor compounds
HRP20181876T1 (hr) Inhibitor za retinokoroidalne poremećaje
HK1219071A1 (zh) 新化合物
AP3850A (en) Azetidinyloxyphenylpyrrolidine compounds
HUP1300280A2 (en) Equipment for increase arm-muscles
EP3010923A4 (en) PYRROLOCHINAZOLINVERBINDUNGEN
EP2948457A4 (en) COMPOUNDS
HK1226072A1 (zh) 作為bcl-3抑制劑的2-苯甲酰氨基苯甲酰胺衍生物
HK1217700A1 (zh) 多晶型物形式
GB201321328D0 (en) Inhibitor compounds
GB201305503D0 (en) Inhibitor
GB201322684D0 (en) New compounds
GB201322678D0 (en) New compounds
GB201322672D0 (en) New compounds
GB201322681D0 (en) New compounds
GB201305946D0 (en) New compounds
GB201305945D0 (en) New compounds
GB201304780D0 (en) New compounds
GB201304782D0 (en) New compounds